Oscillating Magnetic Field Therapy for Contact-Free Cancer Cell Apoptosis

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current cancer treatments, such as chemotherapy and radiotherapy, are devastating to patients and often lead to severe physical and mental trauma, while alternative methods like TTF therapy cause skin lesions and burns, necessitating a less toxic and more effective approach.

Innovation Solution

The application of oscillating magnetic fields (OMFs) generated by rapidly rotating permanent magnets disrupts mitochondrial function in cancer cells, inducing apoptosis through the production of reactive oxygen species (ROS) without direct contact, using miniaturized stimulators that can be configured for specific treatment patterns.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If chemotherapy or radiotherapy is applied to treat cancer, then cancer cells are killed, but severe physical and mental trauma is caused to the patient

Engineering Contradiction:

Improvecancer treatment effectivenessVSAvoidphysical and mental trauma

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces conventional chemotherapy and radiotherapy with a magnetic field-based treatment system. The oscillating magnetic field generated by rotating permanent magnets disrupts mitochondrial electron transport in cancer cells, inducing apoptosis without the severe side effects of chemical or ionizing radiation-based treatments

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent uses oscillating magnetic fields as an intermediary mechanism to kill cancer cells. The magnetic field indirectly disrupts cellular function by affecting electron flow in the mitochondrial electron transport chain, rather than directly attacking cells with toxic chemicals or ionizing radiation

Inventive Principle:

Principle #24Intermediary (Mediator)

2Reliability

If TTF therapy is applied to treat GBM, then therapeutic benefit is achieved, but skin lesions and burns are caused

Engineering Contradiction:

Improvetherapeutic benefitVSAvoidskin lesions and burns

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces electrode-based electrical field delivery with a magnetic field-based system using rotating permanent magnets. This eliminates direct skin contact and the associated risks of lesions, rashes, and burns while maintaining therapeutic effectiveness through magnetic field-induced mitochondrial disruption

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent extracts the harmful electrical current delivery component from the treatment system and replaces it with a magnetic field generation mechanism. The oscillating magnetic field achieves the same therapeutic effect on cancer cells without requiring direct skin contact or electrical current passage through the body

Inventive Principle:

Principle #2Taking out (Extraction)

3Reliability

If conventional cancer treatments are applied, then cancer cells are killed, but the treatment duration is extended due to multiple cycles

Engineering Contradiction:

Improvecancer cell deathVSAvoidtreatment cycle duration

Core Design Contradiction:

ReliabilityVSLoss of time

Solution Approach 1:

The patent employs periodic oscillating magnetic fields generated by rotating magnets to disrupt cancer cell mitochondrial function. The oscillating nature of the magnetic field (typically at frequencies matching mitochondrial membrane potential oscillations) creates cumulative damage to cancer cells over multiple brief treatment sessions, achieving effective cell death in shorter overall treatment durations compared to conventional multi-cycle chemotherapy or radiation protocols

Inventive Principle:

Principle #19Periodic action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method effectively induces cancer cell death while sparing healthy cells, offering a non-invasive, drug-free, and ionizing radiation-free treatment that can be administered in shorter sessions, reducing tumor volume and prolonging patient survival.

Implementation Method 1

rapidly oscillating one or more magnets to generate an oscillating magnetic field (OMF) to disrupt electron flow; for example in the mitochondrial electron transport chain (ETC)

Methodology Applied

Scientific EffectOscillating magnetic field effect on electron flow: Electromagnetic Induction

Implementation Method 2

applying the oscillating magnetic field to the tissue increases the production of reactive oxygen species (ROS)

Methodology Applied

Scientific EffectOscillating magnetic field-induced ROS production: Oxidation

Data Source

PatentUS20260061213A1Method and apparatus for oncomagnetic treatment

Publication Date: 2026.03.05 THE METHODIST HOSPITAL DBA HOUSTON METHODIST HOSPITAL

AI summary

A device for cancer therapy comprises one or more means for producing a magnetic field, where the one or more means for producing a magnetic field oscillate on a first axis and a second axis substantially orthogonal to the first axis. The device further comprises a controller configured to oscillate the means for producing a magnetic field wherein the oscillating frequency reaches a maximum of 50-350 Hz, and, the oscillation of the one or more magnetic fields is at intervals such that the oscillation duration is in a range of 10 milliseconds to 5 seconds, and the duration of an interval between oscillations is in a range of 10 milliseconds to 10 minutes.